Multiple sclerosis patients denied vital drug due to shortage of brain specialists, NHS data shows

Multiple sclerosis patients denied vital drug due to shortage of brain specialists, NHS data shows Patients with multiple sclerosis (MS) are missing out on vital drugs that can put the disease on pause, because there is a nationwide shortage of specialists able to prescribe them.

Nine in ten of those with the incurable neurological disease can't access a drug that can halt progression by up to four years, according to NHS data seen by the MS Society. The Daily Mail